Preparation and Hemocompatibility of Novel Antioxidant‐Modified Polyethersulfone Membranes as Red Blood Cell Thrombosis Inhibitors

Abstract

AbstractThe contact between the dialysis membrane and blood can induce oxidative stress and thrombosis, causing oxidative organ damage and impaired toxin clearance. To date, the selection of anticoagulants has focused on mechanisms inhibiting white, but not red (erythrocytes) thrombus formation. In the present study, polyethersulfone (PES) membranes are modified with the antioxidant drug tiopronin; the physicochemical properties and dialysis performance of the Tio‐PES membranes are evaluated. The effects on erythrocyte thrombosis are evaluated in terms of erythrocyte morphology, prothrombotic properties (adhesion, aggregation, viscosity, sedimentation, and hemolysis), and fibrinogen (FIB)‐erythrocyte interactions. The regular anticoagulant and antiplatelet properties are also assessed. Superoxide dismutase, malondialdehyde, plasma protein, and complement C3a are further determined. Finally, the biosafety of the Tio‐PES membranes is evaluated both in vitro and in vivo. The Tio‐PES membranes exhibit excellent physicochemical properties and improved dialysis performance. It is found that the Tio‐PES membranes stabilize erythrocyte morphology, reduce erythrocyte prothrombotic properties, decrease FIB adsorption, and prevent red thrombus formation. In addition, the Tio‐PES membranes exhibit excellent antioxidant properties and show biosafety in primary toxicity studies. Thus, Tio‐PES membranes hold promise as novel, safe, and effective dialysis materials for potential clinical application.